Hemolytic disease of the newborn (anti-RhE)
HDN due to anti-RhE alloimmunization |
---|
Classification and external resources |
---|
ICD-10 |
P55.8 |
---|
ICD-9 |
773.2 |
---|
Hemolytic disease of the newborn (anti-RhE) is caused by the anti-RhE antibody of the Rh blood group system. The anti-RhE antibody can be naturally occurring, or arise following immune sensitization after a blood transfusion or pregnancy.
The anti-RhE antibody is quite common especially in the Rh genotype CDe/CDe; It usually only causes a mild hemolytic disease, but very rarely can cause a severe condition in the newborn. It can occur with other antibodies, usually the anti-Rhc antibody, which can also cause a severe hemolytic disease.
References
- Antenatal & neonatal screening (second edition). Chapter 12: Rhesus and other haemolytic diseases, by E.A. Letsky, I. Leck, J.M. Bowman. 2000. Oxford University Press. ISBN 0-19-262826-7.
See also
|
---|
| Maternal factors and complications of pregnancy, labour and delivery | |
---|
| Length of gestation and fetal growth | |
---|
| Birth trauma | |
---|
| By system | |
---|
| Infectious | |
---|
| Other | |
---|
| |
---|
| Description |
- Embryology
- Cell lines
- endoderm
- mesoderm
- ectoderm
|
---|
| Disease |
- Due to toxins
- Syndromes
- Chromosomal
- Neonate
- Twins
|
---|
|
---|
| Description |
- Pregnancy
- Development
- Anatomy
|
---|
| Disease |
- Pregnancy and childbirth
- Placenta and neonate
- Infections
- Symptoms and signs
|
---|
| Treatment |
- Procedures
- Drugs
- oxytocins
- labor repressants
|
---|
|
|